Survival of women with advanced ovarian cancer and complete pathologic response at second-look laparotomy
✍ Scribed by Giorgio Bolis; Antonella Villa; Paolo Guarnerio; Cristina Ferraris; Nicoletta Gavoni; Giorgio Giardina; Mauro Melpignano; Giovanna Scarfone; Flavia Zanaboni; Fabio Parazzini
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 377 KB
- Volume
- 77
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
✦ Synopsis
The purpose of the study was to analyze the determinants of long term survival in women with advanced ovarian cancer and negative second-look laparotomy.
METHODS.
A series of 140 advanced (Stage III-rv) ovarian cancer patients (median age, 54 years; range, 22-74 years) with negative second-look laparotomy after primary surgery and chemotherapy is included in the analysis. At first diagnosis, all patients were treated with radical or debulking surgery. After primary surgery, the patients were treated with a chemotherapy regimen based on cisplatin or carboplatin alone or in combination with other drugs. MI second-look laparotomies were performed 6-8 months after first surgery.